PFANSTIEL STEVEN (CFO) received a stock award from MARINUS PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/20/2024ACC: 0001415889-24-017629
Officer· CFO
Since Apr 2021
+70.03K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
70.03K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+12.73K
Price / share
—
Trade value
—
% of position
17.8%
6/18/2024
71.70K→84.43K
Total
Net shares
+12.73K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/18/2024 | A · Award | +12.73K | — | — | 17.8% | 71.70K | 84.43K |
| Total | +12.73K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
57.30K shares
Shares
+57.30K
Strike price
1.40
Held after
57.30K
Exercisable
—
6/18/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock57.30K shares | 6/18/2024 | A · Award | +57.30K | 1.40 | — | 57.30K |